Silvercrest Asset Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.02M | Hold |
|
|||||
|
2025
Q1 | $2.65M | Sell |
|
|||||
|
2024
Q4 | $3.26M | Sell |
|
|||||
|
2024
Q3 | $3.84M | Sell |
|
|||||
|
2024
Q2 | $6.62M | Buy |
|
|||||
|
2024
Q1 | $5.46M | Buy |
|
|||||
|
2023
Q4 | $4.14M | Buy |
|
|||||
|
2023
Q3 | $3.01M | Buy |
|
|||||
|
2023
Q2 | $3.54M | Buy |
|
|||||
|
2023
Q1 | $2.61M | Sell |
|
|||||
|
2022
Q4 | $2.63M | Sell |
|
|||||
|
2022
Q3 | $2.05M | Buy |
|
|||||
|
2022
Q2 | $908K | Sell |
|
|||||
|
2022
Q1 | $2.84M | Buy |
|
|||||
|
2021
Q4 | $4.06M | Buy |
|
|||||
|
2021
Q3 | $1.26M | Sell |
|
|||||
|
2021
Q2 | $5.36M | Buy |
|